Device Center "Grappling" With Banked Samples Policy For IVD Studies
This article was originally published in The Gray Sheet
Executive Summary
FDA's imminent guidance on studies for in vitro diagnostics is unlikely to resolve whether informed consent is necessary for unlinked specimens.